Poseida Therapeutics Appoints Debra Gessner as Vice President, Regulatory Affairs
03 janv. 2017 09h00 HE
|
Poseida Therapeutics, Inc.
SAN DIEGO, Jan. 03, 2017 (GLOBE NEWSWIRE) -- Poseida Therapeutics Inc., a San Diego-based company translating best-in-class gene editing technologies into lifesaving therapeutics, today announced...